Matches in SemOpenAlex for { <https://semopenalex.org/work/W3136281660> ?p ?o ?g. }
- W3136281660 endingPage "267" @default.
- W3136281660 startingPage "267" @default.
- W3136281660 abstract "Doxepin is commonly prescribed for depression and anxiety treatment. Doxepin-related disruptions to metabolism and renal/hepatic adverse effects remain unclear; thus, the underlying mechanism of action warrants further research. Here, we investigated how doxepin affects lipid change, glucose homeostasis, chromium (Cr) distribution, renal impairment, liver damage, and fatty liver scores in C57BL6/J mice subjected to a high-fat diet and 5 mg/kg/day doxepin treatment for eight weeks. We noted that the treated mice had higher body, kidney, liver, retroperitoneal, and epididymal white adipose tissue weights; serum and liver triglyceride, alanine aminotransferase, aspartate aminotransferase, blood urea nitrogen, and creatinine levels; daily food efficiency; and liver lipid regulation marker expression. They also demonstrated exacerbated insulin resistance and glucose intolerance with lower Akt phosphorylation, GLUT4 expression, and renal damage as well as higher reactive oxygen species and interleukin 1 and lower catalase, superoxide dismutase, and glutathione peroxidase levels. The treated mice had a net-negative Cr balance due to increased urinary excretion, leading to Cr mobilization, delaying hyperglycemia recovery. Furthermore, they had considerably increased fatty liver scores, paralleling increases in adiponectin, FASN, PNPLA3, FABP4 mRNA, and SREBP1 mRNA levels. In conclusion, doxepin administration potentially worsens renal injury, nonalcoholic fatty liver disease, and diabetes." @default.
- W3136281660 created "2021-03-29" @default.
- W3136281660 creator A5002060006 @default.
- W3136281660 creator A5003450650 @default.
- W3136281660 creator A5015956903 @default.
- W3136281660 creator A5036561151 @default.
- W3136281660 creator A5049185409 @default.
- W3136281660 creator A5060503044 @default.
- W3136281660 creator A5087011729 @default.
- W3136281660 date "2021-03-16" @default.
- W3136281660 modified "2023-10-17" @default.
- W3136281660 title "Doxepin Exacerbates Renal Damage, Glucose Intolerance, Nonalcoholic Fatty Liver Disease, and Urinary Chromium Loss in Obese Mice" @default.
- W3136281660 cites W1574309809 @default.
- W3136281660 cites W1736508677 @default.
- W3136281660 cites W1813582158 @default.
- W3136281660 cites W1900711358 @default.
- W3136281660 cites W1964350249 @default.
- W3136281660 cites W1976823340 @default.
- W3136281660 cites W1980594673 @default.
- W3136281660 cites W1989373393 @default.
- W3136281660 cites W2000737094 @default.
- W3136281660 cites W2013604729 @default.
- W3136281660 cites W2027513194 @default.
- W3136281660 cites W2035942967 @default.
- W3136281660 cites W2036185264 @default.
- W3136281660 cites W2038201065 @default.
- W3136281660 cites W2039148565 @default.
- W3136281660 cites W2042181529 @default.
- W3136281660 cites W2042881831 @default.
- W3136281660 cites W2045088476 @default.
- W3136281660 cites W2058905991 @default.
- W3136281660 cites W2067977056 @default.
- W3136281660 cites W2075402732 @default.
- W3136281660 cites W2081272758 @default.
- W3136281660 cites W2092297684 @default.
- W3136281660 cites W2102749034 @default.
- W3136281660 cites W2113278271 @default.
- W3136281660 cites W2125718576 @default.
- W3136281660 cites W2128171794 @default.
- W3136281660 cites W2162016578 @default.
- W3136281660 cites W2164367548 @default.
- W3136281660 cites W2165411190 @default.
- W3136281660 cites W2230739551 @default.
- W3136281660 cites W2292214946 @default.
- W3136281660 cites W2315088926 @default.
- W3136281660 cites W2413965494 @default.
- W3136281660 cites W2429892406 @default.
- W3136281660 cites W2552683018 @default.
- W3136281660 cites W2614652454 @default.
- W3136281660 cites W2756117453 @default.
- W3136281660 cites W2782150341 @default.
- W3136281660 cites W2783977704 @default.
- W3136281660 cites W2790662831 @default.
- W3136281660 cites W2804269150 @default.
- W3136281660 cites W2810629608 @default.
- W3136281660 cites W2811420152 @default.
- W3136281660 cites W2881505382 @default.
- W3136281660 cites W2901551978 @default.
- W3136281660 cites W2909321824 @default.
- W3136281660 cites W2911867047 @default.
- W3136281660 cites W2915779412 @default.
- W3136281660 cites W2922257223 @default.
- W3136281660 cites W2939282840 @default.
- W3136281660 cites W2963870036 @default.
- W3136281660 cites W2967985433 @default.
- W3136281660 cites W2968775432 @default.
- W3136281660 cites W2971779721 @default.
- W3136281660 cites W2979900063 @default.
- W3136281660 cites W2980208930 @default.
- W3136281660 cites W2980558423 @default.
- W3136281660 cites W2990183464 @default.
- W3136281660 cites W2991772838 @default.
- W3136281660 cites W2999131584 @default.
- W3136281660 cites W3005672361 @default.
- W3136281660 cites W3014185994 @default.
- W3136281660 cites W3014323041 @default.
- W3136281660 cites W3017152934 @default.
- W3136281660 cites W3025364843 @default.
- W3136281660 cites W3027079514 @default.
- W3136281660 cites W3032465091 @default.
- W3136281660 cites W3035520938 @default.
- W3136281660 cites W3036765043 @default.
- W3136281660 cites W3040453335 @default.
- W3136281660 cites W3047968034 @default.
- W3136281660 cites W3049156115 @default.
- W3136281660 cites W3090213340 @default.
- W3136281660 cites W3119818074 @default.
- W3136281660 cites W3133538340 @default.
- W3136281660 cites W3136523469 @default.
- W3136281660 cites W44605512 @default.
- W3136281660 doi "https://doi.org/10.3390/ph14030267" @default.
- W3136281660 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8001117" @default.
- W3136281660 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33809508" @default.
- W3136281660 hasPublicationYear "2021" @default.
- W3136281660 type Work @default.
- W3136281660 sameAs 3136281660 @default.
- W3136281660 citedByCount "10" @default.
- W3136281660 countsByYear W31362816602021 @default.